✦ LIBER ✦

Transferrin Receptor Targeting Nanomedicine Delivering Wild Type P53 Gene Sensitizes Pancreatic Cancer to Gemcitabine Therapy

✍ Scribed by Camp, E.R.; Wang, C.; Watson, P.; Little, E.; Pirollo, K.F.; Rait, A.; Cole, D.J.; Chang, E.H.; Watson, D.K.

Book ID: 123307790
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 147 KB
Volume: 179
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2012.10.453

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transferrin receptor targeting nanomedic

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

✍ Camp, E R; Wang, C; Little, E C; Watson, P M; Pirollo, K F; Rait, A; Cole, D J; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 402 KB

Drug-resistant human bladder-cancer cell

Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells

✍ Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

We investigated the therapeutic potential and molecular mechanism of adenovirus-mediated wt p53 gene therapy for drug-resistant human bladder cancers. KK47, a human bladder-cancer cell line, along with the drug-resistant sublines KK47/DDP10, KK47/DDP20 (cisplatin-resistant) and KK47/ ADM (doxorubici